A Phase IB/IIA Study of ExoFlo, an Ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Perianal Fistulizing Crohn's Disease
Latest Information Update: 19 Feb 2025
At a glance
- Drugs DB-001 (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Direct Biologics
Most Recent Events
- 11 Feb 2025 Status changed from active, no longer recruiting to discontinued.
- 29 Jul 2024 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2023 Status changed from not yet recruiting to recruiting.